0001062993-21-008463.txt : 20210910 0001062993-21-008463.hdr.sgml : 20210910 20210910152933 ACCESSION NUMBER: 0001062993-21-008463 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 EFFECTIVENESS DATE: 20210910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IntelGenx Technologies Corp. CENTRAL INDEX KEY: 0001098880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870638336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-410238 FILM NUMBER: 211246975 BUSINESS ADDRESS: STREET 1: 6420 ABRAMS CITY: SAINT LAURENT STATE: A8 ZIP: H4S 1Y2 BUSINESS PHONE: 514-331-7440 MAIL ADDRESS: STREET 1: 6420 ABRAMS CITY: SAINT LAURENT STATE: A8 ZIP: H4S 1Y2 FORMER COMPANY: FORMER CONFORMED NAME: BIG FLASH CORP DATE OF NAME CHANGE: 19991112 D/A 1 primary_doc.xml X0708 D/A LIVE 0001098880 IntelGenx Technologies Corp. 6420 ABRAMS VILLE SAINT LAURENT A8 QUEBEC, CANADA H4S 1Y2 514-331-7440 DELAWARE BIG FLASH CORP Corporation true Horst G. Zerbe 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Executive Officer Director Andre Godin 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Executive Officer J. Bernard Boudreau 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Bernd J. Melchers 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director John Marinucci 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Clemens Mayr 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Mark Nawacki 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Srinivas Rao 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Frank Stegert 6420 Abrams Ville Saint-Laurent A8 QUEBEC, CANADA H4S 1Y2 Director Pharmaceuticals Decline to Disclose 06b true 0001062993-21-007597 2021-08-05 false true true true 8% notes convertible to common stock at $0.40 per share. false 10000 Anthony J. Cantone 1066139 Cantone Research Inc 26314 36 Corbett Way Eatontown NJ NEW JERSEY 07724 IL ILLINOIS TX TEXAS FL FLORIDA KS KANSAS NV NEVADA NY NEW YORK AR ARKANSAS CT CONNECTICUT PA PENNSYLVANIA LA LOUISIANA NC NORTH CAROLINA AZ ARIZONA OH OHIO NH NEW HAMPSHIRE TN TENNESSEE MI MICHIGAN NJ NEW JERSEY DC DISTRICT OF COLUMBIA false John Cantone 5190538 Cantone Research Inc 26314 36 Corbett Way Eatontown NJ NEW JERSEY 07724 PA PENNSYLVANIA NC NORTH CAROLINA NH NEW HAMPSHIRE TN TENNESSEE NJ NEW JERSEY false Stephen King 1590508 Cantone Research Inc 26314 36 Corbett Way Eatontown NJ NEW JERSEY 07724 NJ NEW JERSEY false 2500000 2101000 399000 false 34 147070 0 In addition to the maximum cash compensation payable above, broker will receive 4,000 warrants for each $10,000 of convertible note sales, exercisable at $0.40 per share until August 4, 2023. 0 false IntelGenx Technologies Corp. /s/ Andre Godin Andre Godin President & CFO 2021-09-10